Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly teer » significantly better (Expand Search), significantly weaker (Expand Search), significantly lower (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly teer » significantly better (Expand Search), significantly weaker (Expand Search), significantly lower (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
1661
-
1662
-
1663
S1 File -
Published 2024“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”
-
1664
Experimental treatments and groups.
Published 2024“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”
-
1665
Primers for RT-qPCR.
Published 2024“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”
-
1666
Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.
Published 2025Subjects: -
1667
Inequalities in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.
Published 2025Subjects: -
1668
Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.
Published 2025Subjects: -
1669
-
1670
-
1671
-
1672
-
1673
Composition of the gut microbiota at the genus level following the administration of MP.
Published 2025Subjects: -
1674
-
1675
-
1676
-
1677
Activity of xylanase in mixed feed and liver (mg saccharide/g sample/h), n = 12/treatment.
Published 2024Subjects: -
1678
-
1679
Composition of the gut microbiota at the phylum level following the administration of MP.
Published 2025Subjects: -
1680